Development and classification of an operational definition of complementary and alternative medicine for the Cochrane Collaboration

Alternative Therapies in Health and Medicine

Volumn 17, Issue 2, 2011, Pages 50-59

  Susan Wieland, L ^a   Manheimer, Eric ^a   Berman, Brian M ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84866541452     PISSN: 10786791     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. Ezzo J, Wright K, Hadhazy V, et al. Use of the Cochrane electronic library in complementary and alternative medicine courses in medical schools: is the giant lost in cyberspace? J Altern Complement Med. 2002;8(5):681-686.
2. Manheimer E, Wieland S, Kimbrough E, Cheng K, Berman BM. Evidence from the Cochrane Collaboration for Traditional Chinese Medicine therapies. J Altern Complement Med. 2009;15(9):1001-1014.
3. Pelletier KR, Marie A, Krasner M, Haskell WL. Current trends in the integration and reimbursement of complementary and alternative medicine by managed care, insurance carriers, and hospital providers. Am J Health Promot. 1997;12(2):112-122.
4. Astin JA, Marie A, Pelletier KR, Hansen E, Haskell WL. A review of the incorporation of complementary and alternative medicine by mainstream physicians. Arch Intern Med. 1998;158(19):2303-2310.
5. Fontanarosa PB, Lundberg GD. Alternative medicine meets science. JAMA. 1998;280(18):1618-1619.
6. Caspi O, Sechrest L, Pitluk HC, Marshall CL, Bell IR, Nichter M. On the definition of complementary, alternative, and integrative medicine: societal mega-stereotypes vs. the patients' perspectives. Altern Ther Health Med. 2003;9(6):58-62.
7. Barrett B, Marchand L, Scheder J, et al. Themes of holism, empowerment, access, and legitimacy define complementary, alternative, and integrative medicine in relation to conventional biomedicine. J Altern Complement Med. 2003;9(6):937-947.
8. Manheimer E, Anderson BJ, Stein MD. Use and assessment of complementary and alternative therapies by intravenous drug users. Am J Drug Alcohol Abuse. 2003;29(2):401-413.
9. Lachance LL, Hawthorne V, Brien S, et al. Delphi-derived development of a common core for measuring complementary and alternative medicine prevalence. J Altern Complement Med. 2009;15(5):489-494.
10. CAM Research Methodology Conference, April 1995 Panel on Definition and Description. Defining and describing complementary and alternative medicine. Altern TherHealth Med. 1997;3(2):49-57.
11. MediNEWS.Direct! FDA okays Neurostar® TMS system for treating depression. Available at: http://www.medinewsdirect.com/?p=593%29. Accessed January 24, 2011.
12. Ezzo J, Bausell B, Moerman DE, Berman B, Hadhazy V. Reviewing the reviews. How strong is the evidence? How clear are the conclusions? Int J Technol Assess Health Care. 2001;17(4):457-466.
13. Nahim AM. Complementary medicine-new PubMed subset. NLM Tech Bull. 2001 Jan-Feb;318:e7.
14. National Center for Complementary and Alternative Medicine. What is CAM? NCCAM. Available at: http://nccam.nih.gov/health/whatiscam/overview.htm. Accessed April 26, 2010.
15. Engebretson J. A heterodox model of healing. Altern Ther Health Med. 1998;4(2):37-43.
16. Kaptchuk TJ, Eisenberg DM. Varieties of healing. 2: a taxonomy of unconventional healing practices. Ann Intern Med. 2001;135(3):196-204.
17. Tataryn DJ. Paradigms of health and disease: a framework for classifying and understanding complementary and alternative medicine. J Altern Complement Med 2002;8(6):877-892.
18. Jones CH. The spectrum of therapeutic influences and integrative health care: classifying health care practices by mode of therapeutic action. J Altern Complement Med. 2005;11(5):937-944.
19. Myers CD, Bergman J, Zeltzer LK. Complementary and alternative medicine use in children with cancer. In: Kreitler S, Ben Arush MW, eds. Psychosocial Aspects of Pediatric Oncology. Chinchester, England: John Wiley & Sons, Ltd; 2004:335-350.
20. Nathanson I, Sandler E, Ramirez-Garnica G, Wiltrout SA. Factors influencing complementary and alternative medicine use in a multisite pediatric oncology practice. J Pediatr Hematol Oncol 2007;29(10):705-708.